← Eichor
Study identifier: NCT07411352 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Left Lateral Position vs Supine Position to Reduce Active Labor Duration

Condition: Labor Pain  ·  Sponsor: Universidad Nacional Autonoma de Honduras

PhaseNA
Planned participants188
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersYes

About this study

This randomized clinical trial aims to compare the effect of the left lateral decubitus position versus the supine position on the duration of the active phase of labor in nulliparous women. A total of 188 participants will be randomly assigned to one of two groups. The intervention group will be placed in the left lateral decubitus position, while the control group will remain in the supine position. Both positions will be maintained for 30-minute intervals with 5-minute rest periods, continuing until delivery. The primary outcome is the duration of the active phase of labor. Secondary outcomes include rates of cesarean section, use of oxytocin and analgesics, and maternal and neonatal complications.

This description comes directly from the study's public registry record.

Talk to the study team

Ricardo A. Gutierrez Ramirez, MD, MSc  ·  +50497546940  ·  ricardo.gutierrez@unah.edu.hn

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital EscuelaTegucigalpa, Francisco Morazán Department, HondurasRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07411352